Stephanie Ramotar — Seattle University

Area of research

Oncology · Cancer Research

Research interest

Research focused on Transcriptome and Digital health, with related work in Cancer research, Preprint, FOLFIRINOX. Notable publications include 'Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies', 'PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer', and 'Minimally invasive determination of pancreatic ductal adenocarcinoma ( PDAC ) subtype by means of circulating cell‐free RNA'.

Recent publications

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer

Journal of Clinical Oncology 2025cited by 17position: middledoi

Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies

Journal of Medical Internet Research 2024cited by 21position: middledoi

Minimally invasive determination of pancreatic ductal adenocarcinoma ( <scp>PDAC</scp> ) subtype by means of circulating cell‐free <scp>RNA</scp>

Molecular Oncology 2024cited by 3position: middledoi

Minimally invasive determination of PDAC subtype and therapy-induced subtype switch by means of circulating cell-free RNA

Research Square 2024cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Oncology · Cancer Research →